X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Glenmark Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs GLENMARK PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD GLENMARK PHARMA MERCK LTD/
GLENMARK PHARMA
 
P/E (TTM) x 33.1 14.4 230.2% View Chart
P/BV x 3.7 3.8 97.6% View Chart
Dividend Yield % 0.8 0.3 240.1%  

Financials

 MERCK LTD   GLENMARK PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
GLENMARK PHARMA
Mar-17
MERCK LTD/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,060993 106.7%   
Low Rs623729 85.4%   
Sales per share (Unadj.) Rs632.4325.5 194.3%  
Earnings per share (Unadj.) Rs45.739.3 116.3%  
Cash flow per share (Unadj.) Rs62.348.7 128.1%  
Dividends per share (Unadj.) Rs11.002.00 550.0%  
Dividend yield (eoy) %1.30.2 562.8%  
Book value per share (Unadj.) Rs388.8159.2 244.2%  
Shares outstanding (eoy) m16.60282.17 5.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.32.6 50.3%   
Avg P/E ratio x18.421.9 84.0%  
P/CF ratio (eoy) x13.517.7 76.3%  
Price / Book Value ratio x2.25.4 40.0%  
Dividend payout %24.15.1 472.7%   
Avg Mkt Cap Rs m13,969242,991 5.7%   
No. of employees `0001.613.0 12.2%   
Total wages/salary Rs m1,48716,408 9.1%   
Avg. sales/employee Rs Th6,631.97,083.9 93.6%   
Avg. wages/employee Rs Th939.21,265.4 74.2%   
Avg. net profit/employee Rs Th479.4855.1 56.1%   
INCOME DATA
Net Sales Rs m10,49891,857 11.4%  
Other income Rs m242374 64.9%   
Total revenues Rs m10,74192,230 11.6%   
Gross profit Rs m1,13520,367 5.6%  
Depreciation Rs m2762,644 10.4%   
Interest Rs m02,373 0.0%   
Profit before tax Rs m1,10215,724 7.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-810 0.0%   
Tax Rs m3433,827 9.0%   
Profit after tax Rs m75911,088 6.8%  
Gross profit margin %10.822.2 48.8%  
Effective tax rate %31.124.3 128.0%   
Net profit margin %7.212.1 59.9%  
BALANCE SHEET DATA
Current assets Rs m6,41068,746 9.3%   
Current liabilities Rs m8,82827,027 32.7%   
Net working cap to sales %-23.045.4 -50.7%  
Current ratio x0.72.5 28.5%  
Inventory Days Days5885 67.9%  
Debtors Days Days3896 40.2%  
Net fixed assets Rs m1,40624,132 5.8%   
Share capital Rs m166282 58.8%   
"Free" reserves Rs m6,28644,643 14.1%   
Net worth Rs m6,45544,925 14.4%   
Long term debt Rs m045,363 0.0%   
Total assets Rs m8,828117,639 7.5%  
Interest coverage xNM7.6-  
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x1.20.8 152.3%   
Return on assets %8.611.4 75.1%  
Return on equity %11.824.7 47.6%  
Return on capital %17.119.1 89.2%  
Exports to sales %8.30-   
Imports to sales %21.00-   
Exports (fob) Rs m869NA-   
Imports (cif) Rs m2,209NA-   
Fx inflow Rs m95956,152 1.7%   
Fx outflow Rs m2,6128,084 32.3%   
Net fx Rs m-1,65348,068 -3.4%   
CASH FLOW
From Operations Rs m1,0706,574 16.3%  
From Investments Rs m-750-7,124 10.5%  
From Financial Activity Rs m-1505,432 -2.8%  
Net Cashflow Rs m1711,992 8.6%  

Share Holding

Indian Promoters % 0.0 48.3 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 6.9 263.8%  
FIIs % 1.0 34.4 2.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 10.5 277.1%  
Shareholders   28,591 56,727 50.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  NOVARTIS  J.B.CHEMICALS  DR. REDDYS LAB  

Compare MERCK LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 300 Points; Tata Steel Up 3.5%(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading near all-time high levels. Sectoral indices are trading on a positive note.

Related Views on News

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jan 23, 2018 03:34 PM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD - ALEMBIC PHARMA COMPARISON

COMPARE MERCK LTD WITH

MARKET STATS